UBS Group
SPRB icon

UBS Group’s Spruce Biosciences SPRB Stock Holding History

UBS Group’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$384K Sell
7,910
-15,471
-66% -$784K ﹤0.01% 6328
2026
Q2 		$1.26M Buy
23,381
+19,462
+497% +$1.09M ﹤0.01% 5523
2026
Q1 		$256K Sell
3,919
-983
-20% -$67.8K ﹤0.01% 6498
2025
Q4 		$427K Buy
4,902
+4,770
+3,614% +$511K ﹤0.01% 6178
2025
Q3 		$1.18K Buy
+132
New +$1.17K ﹤0.01% 9410
2025
Q2 		– Sell
-1,553
Closed -$33.8K – 11154
2025
Q1 		$33.8K Buy
1,553
+406
+35% +$11.3K ﹤0.01% 7862
2024
Q4 		$36.1K Buy
+1,147
New +$42K ﹤0.01% 7501
2024
Q3 		– Sell
-1,759
Closed -$64.4K – 9383
2024
Q2 		$68.3K Buy
1,759
+1,548
+734% +$83K ﹤0.01% 6446
2024
Q1 		$12.4K Buy
211
+205
+3,417% +$52.1K ﹤0.01% 7138
2023
Q4 		$1.42K Buy
+6
New +$693 ﹤0.01% 8310
2023
Q3 		– Hold
0
– – – 9083
2023
Q2 		– Sell
-13
Closed -$2.17K – 8661
2023
Q1 		$2.12K Sell
13
-62
-83% -$11.5K ﹤0.01% 8574
2022
Q4 		$6.21K Sell
75
-25
-25% -$2.09K ﹤0.01% 9066
2022
Q3 		$10K Buy
100
+22
+28% +$3.08K ﹤0.01% 8464
2022
Q2 		$10K Buy
78
+26
+50% +$3.33K ﹤0.01% 8017
2022
Q1 		$8K Sell
52
-19
-27% -$3.54K ﹤0.01% 8715
2021
Q4 		$24K Buy
+71
New +$21.1K ﹤0.01% 7649
2021
Q1 		– Sell
-63
Closed -$115K – 9575
2020
Q4 		$115K Buy
+63
New +$104K ﹤0.01% 5598

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Carlyle Group
Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return
Quinn Opportunity Partners
Quinn Opportunity Partners Charlottesville, Virginia $1.85B AUM 1.27% 1-Year Est. Return
DMKJ
David M. Knott Jr $183M AUM 73.23% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Persistent Asset Partners
Persistent Asset Partners Hong Kong $362M AUM 191.92% 1-Year Est. Return

UBS Group's SPRB Position: Q3 2026 in Review

UBS Group reduced its Spruce Biosciences (SPRB) stake by 66% in Q3 2026, selling an estimated $784K and leaving 7,910 shares worth $384K. The position accounts for ﹤0.01% of the portfolio, ranked #6328.

UBS Group first reported a position in SPRB in Q4 2020 and has held it in 17 quarters since. The position peaked at $1.26M in Q2 2026. 40 funds tracked by Wall St. Rank hold SPRB as of Q3 2026.

  • UBS Group held 7,910 shares of Spruce Biosciences worth $384K as of Q3 2026.
  • UBS Group sold 15,471 Spruce Biosciences shares in Q3 2026, an estimated $784K.
  • Spruce Biosciences made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #6328 holding.
  • UBS Group first reported a position in Spruce Biosciences in Q4 2020 and has held it in 17 quarters since.
  • UBS Group's Spruce Biosciences position peaked at $1.26M in Q2 2026.
  • 40 funds tracked by Wall St. Rank held Spruce Biosciences as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.